Luis F. Caldera

ORCID: 0009-0005-3254-6563
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • Antimicrobial Peptides and Activities
  • Pancreatic function and diabetes
  • Diabetes and associated disorders
  • Immunotherapy and Immune Responses
  • Diabetes Management and Research
  • vaccines and immunoinformatics approaches
  • interferon and immune responses

California Institute of Technology
2023-2025

Nanoparticle vaccines displaying combinations of SARS-like betacoronavirus (sarbecovirus) receptor-binding domains (RBDs) could protect against SARS-CoV-2 variants and spillover zoonotic sarbecoviruses into humans. Using a computational approach, we designed RBDs selected 7 natural sarbecovirus RBDs, each predicted to fold properly abrogate antibody responses variable epitopes. were attached 60-mer nanoparticles make immunogens two (mosaic-2COMs), five (mosaic-5COM), or seven (mosaic-7COM)...

10.1016/j.cell.2024.12.015 article EN cc-by Cell 2025-01-01

The transplantation of pancreatic endocrine islet cells from cadaveric donors is a promising treatment for type 1 diabetes (T1D), which chronic autoimmune disease that affects approximately nine million people worldwide. However, the demand donor islets outstrips supply. This problem could be solved by differentiating stem and progenitor to cells. many current culture methods used coax differentiate into require Matrigel, matrix composed extracellular (ECM) proteins secreted mouse sarcoma...

10.3389/fbioe.2023.1144209 article EN cc-by Frontiers in Bioengineering and Biotechnology 2023-03-09

1Using computational methods, we designed 60-mer nanoparticles displaying SARS-like betacoronavirus (sarbecovirus) receptor-binding domains (RBDs) by (

10.1101/2024.02.28.582544 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2024-02-28
Coming Soon ...